Array BioPharma Income Statement
View: Annual | Quarterly
| Jun 09 | Jun 08 | Jun 07 | |
|---|---|---|---|
| Revenue | 25.0 | 28.8 | 37.0 |
| Cost of Goods Sold | 19.9 | 21.4 | 24.9 |
| Gross Profit | 5.1 | 7.4 | 12.0 |
| Gross Profit Margin | 20.5% | 25.8% | 32.6% |
| SG&A Expense | 18.0 | 15.6 | 13.6 |
| Depreciation & Amortization | 6.6 | 6.1 | 6.4 |
| Operating Income | (118.1) | -- | -- |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | (17.7) | (1.9) | -- |
| Nonoperating Expenses | (7.9) | 4.1 | -- |
| Income Before Taxes | (128.1) | -- | -- |
| Income Taxes | (0.3) | -- | -- |
| Net Income After Taxes | (127.8) | 0.0 | 0.0 |
| Continuing Operations | (127.8) | (98.2) | (55.4) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (127.8) | (98.2) | (55.4) |
| Total Net Income | (127.8) | (98.2) | (55.4) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (2.67) | (2.04) | (1.36) |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
